Maynard Um
-
-
-
-
-
-
-
Revvity, Inc. (RVTY) Tops Q2 EPS by 20c; Offers Guidance
-
-
-
-
-
-
-
Revvity (RVTY) Reiterated at Hold by Stifel After NDR Lunch With Management
-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Revvity Inc (RVTY)
-
-
-
-
-
-
-
Revvity partners with Sanofi to develop type 1 diabetes screening test
-
-
-
-
-
-
-
Revvity Inc (RVTY) PT Lowered to $100 at Jefferies
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on Revvity Inc (RVTY)
-
-
-
-
-
-
-
Revvity Inc (RVTY) PT Raised to $145 at KeyBanc, Citing 'Organic Growth Guidance'
-
466,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


